Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21169808 | 0.91 | — | — | |
| SCHEMBL22382196 | 0.89 | ALKBH5 (0.31) | — | |
| SCHEMBL21869989 | 0.88 | GAA (0.32) | GAA | |
| SCHEMBL20857989 | 0.84 | MAPT (0.33) | — | |
| SCHEMBL21126537 | 0.83 | — | — | |
| SCHEMBL20857872 | 0.83 | ALKBH5 (0.31) | — | |
| SCHEMBL20857987 | 0.83 | ALKBH5 (0.33) | — | |
| SCHEMBL22047563 | 0.82 | TP53 (0.30) | — | |
| SCHEMBL24719184 | 0.81 | — | — | |
| SCHEMBL21169810 | 0.81 | MEN1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11527720-B1 | Organic electroluminescence device, electronic device, and compound | IDEMITSU KOSAN CO., LTD. (JP) | 2022-12-13 | — | — | US | disclosed |
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190221747-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND NOVEL COMPOUND | KCNN4, OR10J3, KCNN2 | GAA 4419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.